Skip to main content
. 2021 Jun 11;9(5):1662–1671. doi: 10.1111/andr.13061

FIGURE 4.

FIGURE 4

NO‐cGMP pathway in corpus cavernosum. (A) NO concentration in corpus cavernosum measured with a NO assay kit; = 4 for each group. (B) Concentration of cGMP in corpus cavernosum measured with an enzyme‐linked immunosorbent assay kit; = 4 for each group. *: < 0.05 compared with control group. #: < 0.05 compared with JAK2−/− group. §: < 0.05 compared with DM group. DM: diabetes mellitus. cGMP: cyclic guanosine monophosphate